Press coverage about Healthequity (NASDAQ:HQY) has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Healthequity earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.0533904639816 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news articles that may have impacted Accern Sentiment Analysis’s rankings:
- HealthEquity (HQY) Delivers Strong Sales Presentation at JPM Healthcare Conference; Network Partners Up 42% in … – StreetInsider.com (streetinsider.com)
- At $49.41, Is HealthEquity Inc (NASDAQ:HQY) A Buy? (finance.yahoo.com)
- HealthEquity (HQY) Delivers Strong Sales Presentation at JPM Healthcare Conference; Network Partners Up 42% in Fiscal 2018 (streetinsider.com)
- HealthEquity Announces Strong Sales, Presentation at JP Morgan Healthcare Conference (finance.yahoo.com)
Several equities research analysts have recently issued reports on HQY shares. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a research note on Wednesday, October 11th. Robert W. Baird reaffirmed a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Chardan Capital raised their price target on shares of Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research note on Wednesday, December 6th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $56.00 target price on shares of Healthequity in a research report on Tuesday, December 5th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $58.33.
Healthequity (NASDAQ HQY) traded down $0.03 during trading hours on Friday, hitting $48.92. 231,741 shares of the stock were exchanged, compared to its average volume of 490,697. Healthequity has a twelve month low of $37.62 and a twelve month high of $55.31. The company has a market cap of $2,969.92, a PE ratio of 66.11, a P/E/G ratio of 2.02 and a beta of 1.74.
Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. The business had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The company’s revenue was up 31.0% compared to the same quarter last year. During the same period last year, the business earned $0.10 EPS. sell-side analysts predict that Healthequity will post 0.71 earnings per share for the current year.
In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $47.91, for a total transaction of $455,145.00. Following the completion of the sale, the vice president now directly owns 96,500 shares in the company, valued at approximately $4,623,315. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Berkley Capital, Llc sold 373,500 shares of Healthequity stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $53.21, for a total transaction of $19,873,935.00. The disclosure for this sale can be found here. Insiders sold a total of 1,116,434 shares of company stock valued at $58,417,878 over the last quarter. 29.00% of the stock is owned by company insiders.
WARNING: This article was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.thelincolnianonline.com/2018/01/13/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-healthequity-hqy-share-price-updated-updated.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.